Zelira Therapeutics (ZLDAF) Ownership - Who Owns Zelira Therapeutics?
Zelira Therapeutics (ZLDAF) Ownership Overview
- 12.77% Insiders
- 87.23% Public Companies and Individual Investors
The ownership structure of Zelira Therapeutics (ZLDAF) stock is a mix of institutional, retail, and individual investors. , 12.77% is owned by Insiders, and 87.23% is owned by Public Companies and Individual Investors.
The ownership structure of Zelira Therapeutics (ZLDAF) stock is a mix of institutional, retail, and individual investors. , 12.77% is owned by Insiders, and 87.23% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Osagie Imasogie | 1,678,883 | Insider | 12.77% | 16,789 |
FAQ
What percentage of Zelira Therapeutics (ZLDAF) stock is held by retail investors?
According to the latest TipRanks data, approximately 87.23% of Zelira Therapeutics (ZLDAF) stock is held by public companies and individual investors.
Who owns the most shares of Zelira Therapeutics (ZLDAF)?
Osagie Imasogie owns the most shares of Zelira Therapeutics (ZLDAF).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
